Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery. Part II: Arecaidine propargyl ester and pilocarpine loading and in vitro release

International Journal of Pharmaceutics

Volumn 158, Issue 2, 1997, Pages 211-217

  Langer, K ^a   Stieneker, F ^a   Lambrecht, G ^b   Mutschler, E ^b   Kreuter, J ^a  

^a Inst fur Pharmazeut Technol   (Germany)

^b Pharmakol Inst N   (Germany)

Author keywords

Arecaidine propargyl ester; Copolymer; Drug loading; In vitro release; Nanoparticles; Pilocarpine

Indexed keywords

ARECAIDINE PROPARGYL ESTER; COPOLYMER; DRUG CARRIER; MANNITOL; METHACRYLIC ACID METHYL ESTER; METHYLMETHACRYLATE SULFOPROPYLMETHACRYLATE COPOLYMER; NANOPARTICLE; PILOCARPINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; DRUG DETERMINATION; DRUG DIFFUSION; DRUG RELEASE; DRUG TRANSPORT; POLYMERIZATION; PRIORITY JOURNAL; VISCOSITY;

EID: 0031438658     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00256-1     Document Type: Article

References (6)

1. Hagan J.J., van der Heijden B., Broekkamp C.L.E. The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;476-483.
2. Harmia T., Speiser P., Kreuter J. Optimization of pilocarpine loading onto nanoparticles by sorption procedures. Int. J. Pharm. 33:1986;45-54.
3. Langer K., Lambrecht G., Moser U., Mutschler E., Kreuter J. Quantitative colorimetric and gas chromatographic determination of arecaidine propargyl ester (APE). J. Chromatogr. B 692:1997;345-350.
4. Langer K., Marburger C., Berthold A., Kreuter J., Stieneker F. Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery. Part I: preparation and physicochemical characterization. Int. J. Pharm. 137:1996;67-74.
5. 2 receptor subtypes. Br. J. Pharmacol. 96:1989;319-324.
6. Wolf-Pflugmann M., Lambrecht G., Wess J., Mutschler E. Synthesis and muscarinic activity of a series of tertiary and quarternary N-substituted guvacine esters structurally related to arecoline and arecaidine propargyl ester. Arzneim.-Forsch. Drug Res. 39:1989;539-544.